Literature DB >> 28445781

Mitochondrial ROS control of cancer.

María Del Pilar Sosa Idelchik1, Ulrike Begley1, Thomas J Begley1, J Andrés Melendez2.   

Abstract

Mitochondria serves a primary role in energy maintenance but also function to govern levels of mitochondria-derived reactive oxygen species (mROS). ROS have long been established to play a critical role in tumorigenesis and are now considered to be integral to the regulation of diverse signaling networks that drive proliferation, tumor cell survival and malignant progression. mROS can damage DNA, activate oncogenes, block the function of tumor suppressors and drive migratory signaling. The mitochondrion's oxidant scavenging systems including SOD2, Grx2, GPrx, Trx and TrxR are key of the cellular redox tone. These mitochondrial antioxidant systems serve to tightly control the levels of the primary ROS signaling species, H2O2. The coordinated control of mROS levels is also coupled to the activity of the primary H2O2 consuming enzymes of the mitochondria which are reliant on the epitranscriptomic control of selenocysteine incorporation. This review highlights the interplay between these many oncogenic signaling networks, mROS and the H2O2 emitting and consuming capacity of the mitochondria.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidants; Reactive oxygen species; Signal transduction; Tumorigenesis; tRNA

Mesh:

Substances:

Year:  2017        PMID: 28445781      PMCID: PMC5653465          DOI: 10.1016/j.semcancer.2017.04.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  189 in total

Review 1.  Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis.

Authors:  Sang Wook Kang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  CD44 regulates pancreatic cancer invasion through MT1-MMP.

Authors:  Wei Jiang; Yaqing Zhang; Kevin T Kane; Meredith A Collins; Diane M Simeone; Marina Pasca di Magliano; Kevin Tri Nguyen
Journal:  Mol Cancer Res       Date:  2015-01-07       Impact factor: 5.852

Review 3.  Mitochondrial ROS regulation of proliferating cells.

Authors:  Lauren Diebold; Navdeep S Chandel
Journal:  Free Radic Biol Med       Date:  2016-05-03       Impact factor: 7.376

Review 4.  Regulation of protein tyrosine phosphatases by reversible oxidation.

Authors:  Arne Ostman; Jeroen Frijhoff; Asa Sandin; Frank-D Böhmer
Journal:  J Biochem       Date:  2011-08-19       Impact factor: 3.387

5.  Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas.

Authors:  Joon Hyuk Choi; Tae Nyeun Kim; Seongyong Kim; Suk-Hwan Baek; Jung Hye Kim; Seung Rock Lee; Jae-Ryong Kim
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

6.  Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer.

Authors:  Swaroop S Singh; Yun Li; Oscar Harris Ford; Carol S Wrzosek; Diana C Mehedint; Mark A Titus; James L Mohler
Journal:  Transl Oncol       Date:  2008-09       Impact factor: 4.243

7.  Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress.

Authors:  Lucia Biasutto; Antonella Chiechi; Robin Couch; Lance A Liotta; Virginia Espina
Journal:  Exp Cell Res       Date:  2013-05-10       Impact factor: 3.905

8.  Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer.

Authors:  J A Moscow; L Schmidt; D T Ingram; J Gnarra; B Johnson; K H Cowan
Journal:  Carcinogenesis       Date:  1994-12       Impact factor: 4.944

Review 9.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28

10.  Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.

Authors:  H C Whitaker; D Patel; W J Howat; A Y Warren; J D Kay; T Sangan; J C Marioni; J Mitchell; S Aldridge; H J Luxton; C Massie; A G Lynch; D E Neal
Journal:  Br J Cancer       Date:  2013-07-23       Impact factor: 7.640

View more
  64 in total

1.  Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses.

Authors:  Gang Cheng; Jing Pan; Radoslaw Podsiadly; Jacek Zielonka; Alexander M Garces; Luiz Gabriel Dias Duarte Machado; Brian Bennett; Donna McAllister; Michael B Dwinell; Ming You; Balaraman Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

Review 2.  Mitochondrion: I am more than a fuel server.

Authors:  Santanu Dasgupta
Journal:  Ann Transl Med       Date:  2019-10

3.  Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future.

Authors:  Gang Cheng; Monika Zielonka; Brian Dranka; Suresh N Kumar; Charles R Myers; Brian Bennett; Alexander M Garces; Luiz Gabriel Dias Duarte Machado; David Thiebaut; Olivier Ouari; Micael Hardy; Jacek Zielonka; Balaraman Kalyanaraman
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

4.  Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts.

Authors:  Huabo Wang; Jie Lu; Sucheta Kulkarni; Weiqi Zhang; Joanna E Gorka; Jordan A Mandel; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-02-12       Impact factor: 5.157

5.  UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.

Authors:  Jianhua Yu; Lawrence Shi; Weiguo Lin; Baochun Lu; Yunfeng Zhao
Journal:  Biochem Pharmacol       Date:  2019-12-05       Impact factor: 5.858

6.  Dynamic Phosphorylation of the C Terminus of Hsp70 Regulates the Mitochondrial Import of SOD2 and Redox Balance.

Authors:  Sara Zemanovic; Maxim V Ivanov; Lena V Ivanova; Amogh Bhatnagar; Teresa Michalkiewicz; Ru-Jeng Teng; Suresh Kumar; Rajendra Rathore; Kirkwood A Pritchard; Girija G Konduri; Adeleye J Afolayan
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

7.  Low-Temperature EPR Spectroscopy as a Probe-Free Technique for Monitoring Oxidants Formed in Tumor Cells and Tissues: Implications in Drug Resistance and OXPHOS-Targeted Therapies.

Authors:  Balaraman Kalyanaraman; Gang Cheng; Jacek Zielonka; Brian Bennett
Journal:  Cell Biochem Biophys       Date:  2018-09-26       Impact factor: 2.194

Review 8.  DHODH and cancer: promising prospects to be explored.

Authors:  Yue Zhou; Lei Tao; Xia Zhou; Zeping Zuo; Jin Gong; Xiaocong Liu; Yang Zhou; Chunqi Liu; Na Sang; Huan Liu; Jiao Zou; Kun Gou; Xiaowei Yang; Yinglan Zhao
Journal:  Cancer Metab       Date:  2021-05-10

9.  PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma.

Authors:  Bo Wang; Xiaoqin Yin; Weidong Gan; Fan Pan; Shiyuan Li; Zou Xiang; Xiaodong Han; Dongmei Li
Journal:  Autophagy       Date:  2020-10-21       Impact factor: 16.016

10.  Measuring Mitochondrial ROS in Mammalian Cells with a Genetically Encoded Protein Sensor.

Authors:  Xin Zhang; Christine Silvia Gibhardt; Sabrina Cappello; Katharina Maria Zimmermann; Adina Vultur; Ivan Bogeski
Journal:  Bio Protoc       Date:  2018-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.